Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

cemiplimab

- PMLiVE

Pfizer launches personalised lung cancer drug Xalkori in UK

Becomes first treatment on the market for ALK-positive NSCLC

- PMLiVE

FDA approves Exelixis’ Cometriq for rare thyroid cancer

Genomics-based discovery company also submits the drug to EU regulators

- PMLiVE

Sanofi takes anti-counterfeiting message to the skies

Hopes to reach four million passengers with Air France film

Sanofi reception

Sanofi signs $900m allergy collaboration with Selecta

Companies will develop three immunotherapies targeting different allergens

Kala Pharma appoints Fovea founder Bernard Gilly to board

He previously formed the company that became Sanofi’s ophthalmology business

- PMLiVE

Ranbaxy recalls generic Lipitor in US

Several batches withdrawn after some products found to contain small particles of glass

US HHS secretary Sebelius subpoenaed over health reform promotion

House Republicans demand investigation into Affordable Care Act PR

Sanofi reception

Sanofi’s Lyxumia and Zaltrap backed for European approval

Company on course to expand its diabetes and cancer portfolio

- PMLiVE

Sanofi and T1D Exchange collaborate to understand needs of children living with diabetes

Aims to deliver recommendations for better disease management and patient outcomes

- PMLiVE

Obama victory ensures US healthcare reforms will continue

Republican hopeful Mitt Romney unable to act on plan to repeal Affordable Care Act

Sanofi’s Christopher Viehbacher to take the reins at EFPIA

Will serve as European pharma body's president from next June

- PMLiVE

FDA approves Teva’s leukaemia drug Synribo

Accelerated approval means early competition for Pfizer’s Bosulif

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links